Agenus (AGEN) Receivables - Accured (2026)
Agenus (AGEN) posted quarterly Receivables - Accured of $5.2 million for Q4 2025, up 3.58% quarter-over-quarter from $5.0 million in Q3 2025.
Powered by 
Analysis
Agenus (AGEN) Receivables - Accured (2026) Analysis & Trends
Agenus' Receivables - Accured history runs 1 years deep, the most recent figure standing at $5.2 million for Q4 2025.
- In Q4 2025, Receivables - Accured changed N/A year-over-year to $5.2 million; the TTM figure through Dec 2025 stood at $5.2 million (changed N/A YoY), while the FY2025 annual figure was $5.2 million, changed N/A from the prior year.
- Receivables - Accured for Q4 2025 stood at $5.2 million, up from $5.0 million in the prior quarter.
- The five-year high for Receivables - Accured was $5.2 million in Q4 2025, with the low at $5.0 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables - Accured (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Agenus | 342.07 Mn | 342.07 Mn | 34.52 Mn | 100,000.00 |